BiomX posts updated corporate presentation; no material new disclosures

BiomX Inc.

Posted updated slide deck in Investors section of website on June 9, 2025.
Presentation titled 'Clinical Stage Programs Addressing Urgent Need for Overcoming Antibiotic Resistance'.
No specific financial data, guidance changes, or clinical milestones disclosed in the filing.
Filed under Regulation FD; company undertakes no obligation to update the materials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.